JPRN-UMIN000002000已完成2 期
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancer - CAP-002
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 个研究点目标入组 96 人开始时间: 2009年5月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Inadequate physical condition for gemcitabine or S-1 treatmetn according to manufacture's instruction 2. With pulmonary fibrosis or interstitial pneumonia 3. Massive pleural effusion 4. With distant metastasis 5. Active malignancies other than pancreatic cancer 6. Active infectious disease 7. Severe post operative complications 8. Severe angina, cardiac infurction within 3 months at the registration, and severe hear failure 9. Severe diabetes or hypertension 10. Severe mental disorder 11. Pregnancy, breast feeding, or women who desire to preserve fecundity 12. Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
已完成
2 期
A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancerstage III colorectal cancerJPRN-UMIN000001560Boso Clinical Oncology Group140
招募中
2 期
A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDPnon-small cell lung cancerJPRN-UMIN000001765Kyushu University,Graduate School of Medical Science,Department of Surgery and Science140
招募中
2 期
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancerResectable pancreatic cancerJPRN-UMIN000009822Chiba study group of adjuvant chemotherapy for pancreatic cancer74
招募中
1 期
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864EUCTR2021-001085-37-FRInstitut Bergonié66
已完成
不适用
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70